The present invention is an ear cleaner designed to have limited insertion into the ear canal so as not to impact ear wax, also known as cerumen, or damage the ear drum. The ear cleaner has several possible form-factors. All form-factors are designed to be fit over the user's finger. The user's finger is the limiting factor in how far the ear cleaner is inserted. The ear cleaner has a limited surface area. The ear cleaner can have one or more features to entrap ear wax. The ear cleaner is made from a coarse woven fabric to entrap ear wax. The ear cleaner is impregnated with an antimicrobial agent, a lubricant, and a stiffener.

This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.

A system, method, and apparatus are disclosed for dressing a wound. The apparatus comprises a liquid and gas permeable transmission layer, an absorbent layer for absorbing wound exudate, the absorbent layer overlying the transmission layer, a gas impermeable cover layer overlying the absorbent layer and comprising a first orifice, wherein the cover layer is moisture vapor permeable.

The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyimide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.

The present invention relates to a nanofilm including at least one polycation and one polysulfated oligosaccharide. The present invention also relates to the nanofilms obtainable by simultaneously or alternately sputtering at least one polycation solution and at least one polysulfated oligosaccharide solution and to the use of said nanofilms on skin, skin conditions, wounds, or mucous membranes. The present invention also relates to a nanofilm for the use thereof in a method for releasing polysulfated oligosaccharide upon contact with exuding wounds.

A bandage for use at an aggressive bleeding site of a patient is disclosed. The bandage includes a stretchable wrap, an auxiliary strap, a primary absorbent body, and at plural secondary absorbent bodies. The primary absorbent body is located on the inner surface of the wrap. The wrap is arranged to be wrapped about and tightly encircle a portion of the body of a patient at which the bleeding site is located to cause the primary absorbent body to apply pressure thereto. The auxiliary strap is secured to the wrap and is normally held in stowed position on the wrap, but arranged to be moved to an extended position whereupon the secondary absorbent bodies overlies said primary absorbent body and apply pressure thereto and to the underlying aggressive bleeding site.

The resorbable preparation for medical use, and in particular for use as an resorbable dressing for difficult wounds, includes an amorphous hydrogel composed primarily of a mixture of animal collagen, glycerol, xylitol and ozonized vegetable oil in water.

The mixture may include, depending on the applications and methods of preparation: water, in proportion in the range of 10% to 90% by weight; either animal or synthetic collagen, in proportion in the range of 40% to 70% by weight; glycerol, in proportion in the range of 20% to 50% by weight; xylitol, in proportion in the range of 0.05% to 5% by weight; ozonized vegetable oil, in a proportion ranging between 0.001% and 10% by weight; lactoferrin, in proportion in the range of 0.001% to 10% by weight;

The proportion of water is defined as a function of the desired consistency for the resorbable preparation.

The invention provides a dry biocompatible film comprising at least one film forming material and particulate egg shell membrane (ESM), wherein said particulate ESM is distributed substantially uniformly in and/or on the film and wherein said film, or portion thereof, disintegrates upon contact with a wound or an exudate thereof. The invention further provides methods for preparing the films of the invention and the uses thereof in methods to promote the healing of wounds.

Fibres suitable for use in the production of wound dressings comprise carboxymethyl cellulose and alginate in a total amount of at least 90% by weight of the fibre, the carboxymethyl cellulose and alginate are homogeneously distributed throughout the fibre and are present in amounts such that: (a) the amount of carboxymethyl cellulose present in the fibre is at least 50% by weight of the total weight of the carboxymethyl cellulose and alginate; (b) the alginate has a Guluronate-content of 50-90% by weight, and (c) the value of z given by the expression (1): z=(2x/40)/(2x/40)+(y/23) where x and y are the percentages by weight of calcium and sodium respectively in the fibres is at least 80. The fibres may be produced by spinning a solution comprising dissolved CMC and alginate in appropriate proportions into a coagulation bath containing calcium ions.

The disclosure provides methods of treating a wound using negative pressure wound therapy by contacting a wound with a porous fibrin foam dressing and applying negative pressure on the wound, wherein the fibrin foam includes a three-dimensional reaction product of fibrinogen and thrombin and is biodegradable in vivo. Further provided is a dressing material for negative pressure wound therapy comprising a porous fibrin foam that can substantially conform to a shape of the wound, wherein the fibrin foam includes a three-dimensional reaction product of fibrinogen and thrombin, is biodegradable in vivo, and does not need to be changed during the course of therapy.